Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Total	Preferred Stock	Common Stock	Common Stock MultiGen Diagnostics, Inc	Additional Paid-In Capital	Additional Paid-In Capital MultiGen Diagnostics, Inc	Accumulated other comprehensive loss	Accumulated Deficit
Balance (in shares) at Dec. 31, 2013		60,600	18,902,782
Balance at Dec. 31, 2013	$ 20,392,000	$ 60	$ 1,890		$ 87,433,460		$ 0	$ (67,043,410)
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	2,070,195				2,070,195
Issuance of warrant in connection with debt agreement	235,857				235,857
Issuance of common stock upon net exercise of warrant (in shares)			13,011	13,011
Issuance of common stock upon net exercise of warrant				$ 1		$ (1)
Unrealized loss from foreign currency translation	0
Unrealized loss on securities available-for-sale	0
Preferred stock dividend	(23,015)							(23,015)
Net loss	(14,325,484)							(14,325,484)
Balance (in shares) at Dec. 31, 2014		60,600	18,915,793
Balance at Dec. 31, 2014	8,349,553	$ 60	$ 1,891		89,739,511		0	(81,391,909)
Increase (Decrease) in Stockholders' Equity
Sale of common stock, net of expenses (in shares)			9,996,531
Sale of common stock, net of expenses	61,215,399		$ 1,000		61,214,399
Stock-based compensation	3,946,027				3,946,027
Derivative financial instruments—Warrants liability reclassified to additional paid-in capital	435,365				435,365
Issuance of common stock upon net exercise of warrant (in shares)			277,136
Issuance of common stock upon net exercise of warrant	0		$ 28		(28)
Issuance of common stock upon exercise of warrant (in shares)			282,975
Issuance of common stock upon exercise of warrants	1,389,427		$ 28		1,389,399
Issuance of common stock upon exercise of stock options (in shares)			265,166
Issuance of common stock upon exercise of stock options	860,852		$ 27		860,825
Preferred stock dividend	(24,240)							(24,240)
Net loss	(27,471,094)							(27,471,094)
Balance (in shares) at Dec. 31, 2015		60,600	29,737,601
Balance at Dec. 31, 2015	48,701,289	$ 60	$ 2,974		157,585,498		0	(108,887,243)
Increase (Decrease) in Stockholders' Equity
Sale of common stock, net of expenses (in shares)			421,810
Sale of common stock, net of expenses	2,285,415		$ 42		2,285,373
Stock-based compensation	7,504,316				7,504,316
Issuance of warrant in connection with debt agreement	148,885				148,885
Issuance of common stock upon net exercise of warrant (in shares)			2,651
Issuance of common stock upon net exercise of warrant	0		$ 0		0
Issuance of common stock upon releases of restricted stock units (in shares)			95,000
Issuance of common stock upon releases of restricted stock units			$ 10		(10)
Unrealized loss from foreign currency translation	(1,708)						(1,708)
Unrealized loss on securities available-for-sale	(9,065)						(9,065)
Issuance of common stock upon net exercise of stock option (in shares)			341,333
Issuance of common stock upon net exercise of stock options			$ 34		(34)
Issuance of common stock upon exercise of stock options (in shares)			98,396
Issuance of common stock upon exercise of stock options	366,966		$ 10		366,956
Preferred stock dividend	(24,240)							(24,240)
Net loss	(39,203,719)							(39,203,719)
Balance (in shares) at Dec. 31, 2016		60,600	30,696,791
Balance at Dec. 31, 2016	$ 19,768,139	$ 60	$ 3,070		$ 167,890,984		$ (10,773)	$ (148,115,202)